HLA-G & B2M & Peptide (RIIPRHLQL)

HLA-G & B2M & Peptide (RIIPRHLQL) 製品リスト

  • 属性

    Protein (2)

  • 製品ライブラリ

    オンライン (2)

  • Human (2)

  • タグ

    His Tag (1)His Tag & Avi Tag (1)

  • マーカー

    Unconjugated (1)Biotin-labeled (1)

HLA-G & B2M & Peptide (RIIPRHLQL)バックグランド

Human leukocyte antigen-G (HLA-G) is a group of closely linked genes located on the short arm of human chromosome 6. Hla-g belongs to a non-classical major histocompatibility complex. MHC class I molecules are selectively highly expressed in extravvillous trophoblast cells invading the uterine decidual membrane.The gene structure of HLA-G is similar to that of HLA-A,HLA-B and HLA-C, but the termination code appears in advance so that the intracellular segment of protein product encoded by HLA-G is only 6 amino acids, which is significantly shorter than the 30 amino acids of classical HLA classI antigen. The Human HLA-G & B2M & RIIPRHLQL Complex Protein is a complex of HLA-G of the MHC Class I, B2M and RMFPNAPYL peptide.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
OsugacestatAL-101(BMS); BMS-906024Phase 2 ClinicalBristol-Myers Squibb Company, Glaxosmithkline PlcTriple Negative Breast Neoplasms; Neoplasms; Carcinoma, Adenoid Cystic; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8